MONTPELIER (AP) -- The state of Vermont will get $3.9 million under a health care fraud settlement in which drug maker Merck & Co. will pay $671 million to settle claims it overcharged the government, ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

A lawsuit believed to be the first in Vermont against the maker of the drug Vioxx has been filed by a South Burlington woman who took the drug for more than two years. However, the lawsuit filed this ...

Merck aims to boost its business by buying Verona Pharma for $10 billion. Through the deal, it will add Ohtuvayre -- a treatment for COPD -- to its portfolio. With the stock valued at only 12 times ...

April 24 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics (SWTX.O), opens new tab for about $3.5 ...

Oct 19 (Reuters) - A federal judge has approved a $70 million settlement reached by a class of drug purchasers with Merck & Co Inc and Glenmark Pharmaceuticals over claims that the two drugmakers ...

Burlington, Mass.-based Arcadia Healthcare Solutions received $30 million in capital growth investments. New investors include Merck Global Health Innovation Fund and GE Ventures. Previous investors ...

Drug maker Merck announced Tuesday it will embark on an initiative to cut $3 billion in costs 2027, including an undisclosed amount of layoffs. The global health care company, which has U.S.

Merck, the New Jersey-based pharmaceutical company, Glenmark Pharmaceuticals and other defendants were slapped with an antitrust lawsuit Thursday in Virginia Eastern District Court. The court action, ...